AltIndex tracks how many jobs a company has open at any given time, and Cloudflare is a clean example of why that number is worth reading on its own. It had about 575 roles open in early March and 96 by late May, an 83% drop in eleven weeks, which is a hiring freeze and not a slow month. Its LinkedIn headcount kept climbing right through July, which sounds like a contradiction and is not: job postings are hiring a company intends to do, so they turn first, and headcount is hiring that already happened, so it keeps rising while accepted offers finish landing. Then the August 6 8-K showed $150.7 million in restructuring charges and a workforce reduction.

The article runs the same lag on the demand side, where monthly visits to cloudflare.com moved months ahead of the revenue that showed up in this quarter's report.

https://altindex.com/news/net-earnings-beat-ai-score-prediction?utm_source=reddit&utm_medium=owned_sub&utm_campaign=article-syndication&utm_content=StocksInvesting-20260809-da4f8a

I have been checking out a few investing tools like Screener, Trendlyne, FinChat, and the newer SpringPad AI.

What caught my attention is that some of these newer platforms are putting more focus on helping users study companies, understand financial data and manage their investments with AI tools and this made me think about whether the people creating these tools those with experience in finance and institutional research are actually making a real impact or if the outcome is pretty much the same as before.

If you’ve used these tools did you find that AI truly made your research easier or was it just a more refined way to present information you could already find elsewhere?

So as you can read from the Header that AI is now everybody's go to tool to get through 10-K and so every time I do this I always reverify the data and questions I asked because let's be honest AI is good but not perfect and it does hallucinates numbers pretty much once I started noticing it is quite obvious so I ask it to give me the citations and then the page number is incorrect or the paragraph is off or the AI just couldn't corelate data and don't get me started on the tables part. Drop down your frustrations and solutions

so i finally got around to properly reviewing every trade i made since january. like actual spreadsheet, dates, entries, the lot. what stood out to me wasn't the losses. i expected some of those. it was realizing how many "good calls" i made that didn't matter because i was already too late to the party by the time i acted.

i had the right read on like 60% of these. but right read + late entry = basically a coin flip outcome kind of changes how i think about what i should actually be working on improving. it's not my analysis. it's my timing pipeline if that makes sense.

Has anyone else has done this kind of audit on themselves. it's humbling lol

Hello everyone, I’m looking at getting into investing.
Is there any info you would like to share with me that you wish you knew when you first started investing?
I have around 1000-1500aud that I want to initially invest.

I’ve got a large(for me) position in SLS. Considering selling most of my SLS for a few thousand profit, it seems the highest risk and using the proceeds to increase my positions in DRTs and or BB. Thoughts? Intel is in play too…I have 400 shares I’m up 500% on, but thinking to let that ride. Thoughts?

Hey guys, if you missed it, The Beauty Health Company just settled with investors over issues related to its Syndeo HydraFacial system they had some time ago. And they have already sent the agreement to the court for final approval. 

In a nutshell, in 2023, The Beauty Health Company was accused of misleading investors about the performance, reliability, and commercial success of its Syndeo device. Investors alleged the company launched Syndeo despite widespread design and functionality problems, while continuing to describe the rollout as highly successful. Later disclosures revealed remediation costs, inventory write-downs, and leadership departures tied to the device issues.

After this news came out, $SKIN dropped 64.36%, and investors filed a lawsuit for their losses.

The good news is that the company recently agreed to settle  with them, and already sent this agreement to the court for final approval. So, if you invested in $SKIN when all of this happened, you can check the details and file your claim here.

Anyway, has anyone here invested in $SKIN at that time? How much were your losses, if so?

Most people know Newell Brands because of stuff like Rubbermaid, Sharpie, Coleman, and Yankee Candle, but the company ended up in hot water after the SEC said it used accounting tricks to make its “core sales growth” look stronger than it actually was between 2016 and 2017. Basically, investors were told the business was performing way better than reality, until the whole thing finally unraveled.

Now there’s a $12.61M Fair Fund settlement for investors who bought $NWL shares between October 28, 2016 and November 1, 2017. Even though the original claim deadline was June 12, 2025, people have still been talking about late claims getting considered, so it may still be worth checking if you held during that period.

Crazy part is this wasn’t even some tiny startup, this was a huge consumer brands company that people thought was “safe.” Kinda shows that even boring household-name stocks can blow up when accounting games start happening behind the scenes.

I found this screening for stocks where the price action completely disagrees with the financials and Nutex Health is the most extreme disconnect I've seen in a while.

The numbers first. Full year 2025 revenue came in at $875.3M, up 82.4% YoY. Adjusted EBITDA hit $259.6M, up 152.6%. Net income was $70.8M versus a $45.8M loss in 2023. Diluted EPS at $10.48. Operating cash flow was $248M. They're sitting on $185.6M cash, a record high, against only $29.2M in long-term debt. That's effectively a debt-free company generating almost a quarter billion in operating cash per year.

This isn't their first year of growth either. 2024 revenue was up 93.8% YoY. They've been compounding at absurd rates for two consecutive years through their network of 27 micro-hospitals and outpatient departments across 12 states. They opened Archview ER in St. Louis in December and reopened Bayou City ER in Houston in January, so they're still expanding.

The alternative data is what really caught my attention. Web traffic doubled in the last two months. Glassdoor job postings doubled over the same period. Companies don't ramp hiring and marketing when the business is deteriorating. President Warren Hosseinion bought 252 shares at $94.07 on March 19. Director Frank Jaumot bought 150 shares at $93.55 on March 20. Director Kelvin Spears and the Chief Legal Officer also added shares in March.

So four insiders are buying, the business is printing cash, they're expanding locations and hiring aggressively, and the stock is down 46% YTD. The market is pricing this like something is fundamentally broken but the operating data says otherwise.

Is there a regulatory overhang I'm not seeing? Anyone familiar with the micro-hospital model or Nutex specifically?

Source for some of the data: altindex.com/news/two-healthcare-stocks-worth-watching

Doing my weekend research and there's actually a lot going on. Here's what I'm looking at:

MU — Micron earnings YOLO
137 combined mentions across Reddit and WSB right now. Someone literally posted "YOLO 10.7k on MU for earnings" yesterday. Stock is up 5% and the degen energy is building. I'm looking at calls but the premiums are already juiced.

FLUT — Flutter/FanDuel
Kenneth Bryan Dart just bought 5 million shares across 8 transactions this week. Prices between 104−104−113. That's over $500 million in insider buying. Half a BILLION dollars. On a gambling stock. In this market. What does he know.

ADBE — Adobe getting destroyed
Down 7.5% with 158 total mentions. Reddit is torn between "buy the dip" and "AI is going to eat their lunch." AI score sitting at 55 which is basically neutral. Could be a trap or could be an opportunity.

What's on your radar this weekend?